Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price9.63 USD
Fair value11.50
Ethical score30.0/100
Our investment reviews on this name
2026-10-02Read Distribution9.63+0.0% to today
2026-08-31Read Markdown10.08-4.5% to today ✓
2026-07-31Read Markup10.09-4.6% to today
2026-07-02Read Markdown8.91+8.1% to today
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Genworth Financial, Inc. holds its Distribution at $9.63. The statistical read favours the sellers, held for 192 days.
As held on the ledger · 2026-09-23
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 192 days
Price at the screen
$9.63
Valuation
18.88 trailing · 8.75 forward price to earnings
Values screen
FAIL· score 30.0
Beta
0.86
The Workings
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: insurance
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Prohibited keyword in sector/industry: insurance
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Genworth Financial, does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
Fair value range in USD, drawn from the 2026-09-23 screen. The gold marker is the market price at the same screen. A 19.4% margin of safety to the base estimate.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Insurance Cover Rarely Survives Close Ethical Scrutiny
Picture a family paying premiums for decades only to discover the fine print leaves them exposed when claims arrive. Genworth sits in exactly that line of work, selling mortgage and long term care policies through its two main segments. The numbers show flat revenue, a 3 percent profit margin and 3 percent return on equity, so the business already offers little room for error.
We pass for the clearest reason possible. The ethical screen rejects the entire insurance sector outright, and nothing in the current figures changes that view. A 9.2 times forward multiple and a single analyst target of twelve dollars against a ten dollar share price look cheap only until the sector ban is applied.
Low returns and zero growth already signal limited durability even before ethics enter the frame. Currency or claims shocks would simply widen the gap. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
GNW trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-02Distribution · changed$9.63-4.5%Entry 6
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $11.
2026-08-31Markdown · changed$10.08-0.1%Entry 5
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $11.
2026-07-31Markup · changed$10.09+13.2%Entry 4
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 13.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $11.
2026-07-18Markdown$8.91+0.0%Entry 3
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $11.
2026-07-03Markdown$8.91+0.0%Entry 2
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Markdown$8.91Entry 1
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
